Suspected sepsis in people aged 16 or over: recognition, assessment and early management (NG253)Product type:GuidanceProgramme:NICE guidelinePublished: 19 November 2025
Suspected sepsis in pregnant or recently pregnant people: recognition, diagnosis and early management (NG255)Product type:GuidanceProgramme:NICE guidelinePublished: 19 November 2025
Suspected sepsis in under 16s: recognition, diagnosis and early management (NG254)Product type:GuidanceProgramme:NICE guidelinePublished: 19 November 2025
Pneumonia: diagnosis and management (NG250)Product type:GuidanceProgramme:NICE guidelinePublished: 2 September 2025
Urinary tract infection (recurrent): antimicrobial prescribing (NG112)Product type:GuidanceProgramme:NICE guidelineLast updated: 12 December 2024Published: 31 October 2018
Neonatal infection: antibiotics for prevention and treatment (NG195)Product type:GuidanceProgramme:NICE guidelineLast updated: 19 March 2024Published: 20 April 2021
Cefiderocol for treating severe drug-resistant gram-negative bacterial infections (AMR2)Product type:GuidanceProgramme:Antimicrobial resistance guidancePublished: 17 August 2022
Ceftazidime with avibactam for treating severe drug-resistant gram-negative bacterial infections (AMR1)Product type:GuidanceProgramme:Antimicrobial resistance guidancePublished: 17 August 2022
Otitis media (acute): antimicrobial prescribing (NG91)Product type:GuidanceProgramme:NICE guidelineLast updated: 11 March 2022Published: 28 March 2018
Clostridioides difficile infection: antimicrobial prescribing (NG199)Product type:GuidanceProgramme:NICE guidelinePublished: 23 July 2021
Secondary bacterial infection of eczema and other common skin conditions: antimicrobial prescribing (NG190)Product type:GuidanceProgramme:NICE guidelinePublished: 2 March 2021
Human and animal bites: antimicrobial prescribing (NG184)Product type:GuidanceProgramme:NICE guidelinePublished: 4 November 2020
Insect bites and stings: antimicrobial prescribing (NG182)Product type:GuidanceProgramme:NICE guidelinePublished: 22 September 2020
Surgical site infections: prevention and treatment (NG125)Product type:GuidanceProgramme:NICE guidelineLast updated: 19 August 2020Published: 11 April 2019
Impetigo: antimicrobial prescribing (NG153)Product type:GuidanceProgramme:NICE guidelinePublished: 26 February 2020
Leg ulcer infection: antimicrobial prescribing (NG152)Product type:GuidanceProgramme:NICE guidelinePublished: 11 February 2020
Cellulitis and erysipelas: antimicrobial prescribing (NG141)Product type:GuidanceProgramme:NICE guidelinePublished: 27 September 2019
Cough (acute): antimicrobial prescribing (NG120)Product type:GuidanceProgramme:NICE guidelinePublished: 7 February 2019
Bronchiectasis (non-cystic fibrosis), acute exacerbation: antimicrobial prescribing (NG117)Product type:GuidanceProgramme:NICE guidelinePublished: 18 December 2018
Chronic obstructive pulmonary disease (acute exacerbation): antimicrobial prescribing (NG114)Product type:GuidanceProgramme:NICE guidelinePublished: 5 December 2018
Urinary tract infection (catheter-associated): antimicrobial prescribing (NG113)Product type:GuidanceProgramme:NICE guidelinePublished: 23 November 2018
Prostatitis (acute): antimicrobial prescribing (NG110)Product type:GuidanceProgramme:NICE guidelinePublished: 31 October 2018
Pyelonephritis (acute): antimicrobial prescribing (NG111)Product type:GuidanceProgramme:NICE guidelinePublished: 31 October 2018
Urinary tract infection (lower): antimicrobial prescribing (NG109)Product type:GuidanceProgramme:NICE guidelinePublished: 31 October 2018
Sore throat (acute): antimicrobial prescribing (NG84)Product type:GuidanceProgramme:NICE guidelinePublished: 26 January 2018
Sinusitis (acute): antimicrobial prescribing (NG79)Product type:GuidanceProgramme:NICE guidelinePublished: 27 October 2017
Antimicrobial stewardship: changing risk-related behaviours in the general population (NG63)Product type:GuidanceProgramme:NICE guidelinePublished: 25 January 2017
Antimicrobial stewardship: systems and processes for effective antimicrobial medicine use (NG15)Product type:GuidanceProgramme:NICE guidelinePublished: 18 August 2015
Antimicrobial prescribing: eravacycline for complicated intra-abdominal infections in adults (ES40)Product type:AdviceProgramme:Evidence summaryPublished: 11 May 2022
Antimicrobial prescribing: oritavancin for acute bacterial skin and skin structure infections (ES39)Product type:AdviceProgramme:Evidence summaryPublished: 11 May 2022
Antimicrobial prescribing: delafloxacin for community-acquired pneumonia (ES37)Product type:AdviceProgramme:Evidence summaryPublished: 10 August 2021
Antimicrobial prescribing: delafloxacin for acute bacterial skin and skin structure infections (ES32)Product type:AdviceProgramme:Evidence summaryPublished: 5 January 2021
Antimicrobial prescribing: imipenem with cilastatin and relebactam (ES30)Product type:AdviceProgramme:Evidence summaryPublished: 28 October 2020
Antimicrobial prescribing: ceftolozane with tazobactam for treating hospital-acquired pneumonia, including ventilator-associated pneumonia (ES22)Product type:AdviceProgramme:Evidence summaryPublished: 18 December 2019
Antimicrobial prescribing: meropenem with vaborbactam (ES21)Product type:AdviceProgramme:Evidence summaryPublished: 20 November 2019
Fungitell for antifungal treatment stratification (MIB118)Product type:AdviceProgramme:Medtech innovation briefingPublished: 31 August 2017
eazyplex SuperBug kits for detecting carbapenemase-producing organisms (MIB94)Product type:AdviceProgramme:Medtech innovation briefingPublished: 7 February 2017
Alere Afinion CRP for C-reactive protein testing in primary care (MIB81)Product type:AdviceProgramme:Medtech innovation briefingPublished: 14 September 2016
QuikRead go for C-reactive protein testing in primary care (MIB78)Product type:AdviceProgramme:Medtech innovation briefingPublished: 14 September 2016
Xpert Carba-R to identify people carrying carbapenemase-producing organisms (MIB52)Product type:AdviceProgramme:Medtech innovation briefingPublished: 12 February 2016
Clostridium difficile infection: risk with broad-spectrum antibiotics (ESMPB1)Product type:AdviceProgramme:Evidence summaryPublished: 17 March 2015